atovaquone has been researched along with Brain Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayuk, F; Bacher, A; Bacher, U; Christopeit, M; Klyuchnikov, E; Kröger, N; Langebrake, C; Mendorf, A; Regier, M; Rohde, H; Stübig, T; Wolschke, C; Zabelina, T | 1 |
1 other study(ies) available for atovaquone and Brain Disorders
| Article | Year |
|---|---|
Atovaquone for Prophylaxis of Toxoplasmosis after Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Atovaquone; Brain Diseases; Female; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies; Toxoplasmosis; Transplantation, Homologous; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2015 |